COMPANY SEARCH RESULT
Last update : 03/04/2012 >View issuer details
2019.04.29 | 14:00 | Permanent Information Releases / General Company News
2019.04.25 | 11:30 | Share History / Voting Rights and Number of Shares
Decision by the Board of Directors to acquire own shares - HTML (w)
2019.04.25 | 11:00 | Periodic information / 1st Quarter Information
2019.04.16 | 08:00 | Share History / Voting Rights and Number of Shares
297,000 Orion Corporation A shares converted into B shares - HTML (w)
2019.04.11 | 09:30 | Permanent Information Releases / Notification of availability
Publishing of Orion Corporation's Interim Report for January-March 2019 on 25 April 2019 - HTML (w)
2019.03.27 | 14:16 | Permanent Information Releases / General Company News
Invitation to Orion's Capital Markets Day in Helsinki on Wednesday 22 May 2019 - HTML (w)
2019.03.26 | 16:30 | Annual General Meeting / AGM
Orion Corporation: Organising meeting of the Board of Directors - HTML (w)
2019.03.26 | 15:45 | Annual General Meeting / AGM
Orion Corporation: Decisions by the AGM on 26 March 2019 - HTML (w)
2019.03.08 | 07:30 | Permanent Information Releases / General Company News
Darolutamide submitted for European marketing authorization - HTML (w)
2019.03.05 | 07:00 | Permanent Information Releases / General Company News
Darolutamide submitted for marketing authorization in Japan - HTML (w)
2019.03.04 | 11:00 | Permanent Information Releases / Notification of availability
2019.03.01 | 18:10 | Share History / Voting Rights and Number of Shares
Orion Corporation: Transfer of 47,279 own B shares on 1 March 2019 - HTML (w)
2019.02.27 | 06:00 | Permanent Information Releases / General Company News
The rolling submission to FDA for darolutamide in the U.S. completed - HTML (w)
2019.02.14 | 22:45 | Permanent Information Releases / General Company News
2019.02.11 | 15:00 | Permanent Information Releases / General Company News
Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 188
